about
Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practiceProgress of in vitro factor VIII coagulant activity from 0 to 8 hours after reconstitution.Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia.Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors.Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections.Continuous infusion in haemophilia: current practice in Europe.
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Continuous infusion.
@ast
Continuous infusion.
@en
type
label
Continuous infusion.
@ast
Continuous infusion.
@en
prefLabel
Continuous infusion.
@ast
Continuous infusion.
@en
P2860
P1433
P1476
Continuous infusion
@en
P2093
Schulman S
P2860
P304
P356
10.1046/J.1365-2516.2003.00765.X
P50
P577
2003-07-01T00:00:00Z